Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 26: 305-308, 1980;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonderman, D. P.
Right arrow Articles by Haskins, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonderman, D. P.
Right arrow Articles by Haskins, S.

Clinical Chemistry, Vol 26, 305-308, Copyright © 1980 by American Association for Clinical Chemistry

A lyophilized hemoglobin control prepared from stroma-free hemolysates

DP Bonderman, GJ Proksch and S Haskins

We prepared a stable lyophilized hemoglobin control from human erythrocytes by removing stroma with calcium and Ficoll. Addition of polyhydroxy compounds enhanced reconstitution and stability. The lyophilized product was stable during one year of use in a service laboratory. Accelerated aging studies demonstrated the potential of up to two years of stability, with methemoglobin increasing at a projected rate of approximately 6% per year. Reconstituted, the control gave reproducible values for at least five days when refrigerated.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the American Association for Clinical Chemistry.